Josh Zibit | Head of Technical Development
Astellas Gene Therapies | United States

Josh Zibit is the Head of Technical Development at Astellas Gene Therapies. He has over 15 years’ experience in biopharma working on diverse biologics including gene therapies, antibodies, and antibody-drug conjugates, and more than 7 years’ experience in gene therapy programs. At Astellas Gene Therapies, he leads a team responsible for the overall CMC development of all products, including transfer of processes and methods to GMP manufacturing and testing sites.